News

Stay up to date on our latest stories.

Filters
Decorative image.
New

Inspiring women of Hikma - Meet Stephanie Haas, Senior Director, Head of Hikma Rx Procurement

Story, Leadership 05 June 2025
Inspiring women of Hikma - Meet Stephanie Haas, Senior Director, Head of Hikma Rx Procurement
Decorative image.

Hikma launches Triamcinolone Acetonide Injectable Suspension, USP, in the US

Press Release, Product 05 June 2025
Hikma launches Triamcinolone Acetonide Injectable Suspension, USP, in the US
Decorative image.

Fitch upgrades Hikma Pharmaceuticals PLC’s long-term issuer default rating to ‘BBB’, outlook stable

Press Release, Corporate 29 May 2025
Fitch upgrades Hikma Pharmaceuticals PLC’s long-term issuer default rating to ‘BBB’, outlook stable
Decorative image.

Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosim...

Press Release, Product 27 May 2025
Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosim...
Decorative image.
New

Hikma announces strong medium-term Group guidance ahead of its US site visit

Press Release, Corporate 15 May 2025
Hikma announces strong medium-term Group guidance ahead of its US site visit
Decorative image.
New

Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits

Press Release, Corporate 08 May 2025
Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits
Decorative image.

S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable

Press Release, Corporate 08 May 2025
S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable
Decorative image.

Hikma reiterates full year guidance following good start to the year

Press Release, Corporate 24 April 2025
Hikma reiterates full year guidance following good start to the year
Decorative image.

Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France

Insight, Life at Hikma 17 April 2025
Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France
Decorative image.

Hikma acquires Novugen’s FDA-approved ANDA for trametinib

Press Release, Product 17 April 2025
Hikma acquires Novugen’s FDA-approved ANDA for trametinib
Decorative image.

Hikma signs exclusive licensing agreement with pharma& to bring innovative oncology treatment to MENA

Press Release, Business Development 09 April 2025
Hikma signs exclusive licensing agreement with pharma& to bring innovative oncology treatment to MENA
Decorative image.
New

Hikma launches Cisatracurium Besylate Injection, USP in the US

Press Release, Product 25 March 2025
Hikma launches Cisatracurium Besylate Injection, USP in the US
Decorative image.
New

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Press Release, Product 20 March 2025
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Decorative image.
New

Developing our pipeline in growing therapeutic areas

Story, Corporate 19 March 2025
Developing our pipeline in growing therapeutic areas
Decorative image.
New

Focusing on our quality manufacturing

Story, Corporate 19 March 2025
Focusing on our quality manufacturing

You have viewed 15 of 484 results